Internal Medicine, General Medicine Conference-IPSC 2026

Diabetes and endocrine disorders are at the forefront of internal medicine challenges, with rising prevalence and complex management needs. This session will provide a comprehensive overview of new therapeutic strategies, from novel insulin delivery systems and continuous glucose monitoring to emerging drug classes for type 2 diabetes. Special focus will be given to comorbidities such as cardiovascular disease, kidney dysfunction, and obesity.

The session will also explore thyroid disorders, adrenal dysfunctions, and metabolic syndromes, emphasizing how internal medicine integrates multidisciplinary care for optimal outcomes. Endocrine disruption from environmental and genetic factors will also be discussed. By combining evidence-based treatment with innovations in digital health monitoring, this session underscores the evolving role of internal medicine in combating the global diabetes epidemic and endocrine imbalances.